Does Brachytherapy Boost Improve Biochemical Control in Intermediate and High-Risk Prostate Cancer Patients Compared to External Beam Radiotherapy Alone?

M Miszczyk,I Jabłońska, T Krzysztofiak,Ł Magrowski,W Majewski,R Suwiński, O Masri, J Ciepał, G Depowska, M Gmerek,E Nowicka, P A Wojcieszek

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS（2021）

引用 0|浏览1

暂无评分

摘要

The combination of EBRT and BT boost has the potential to significantly improve biochemical control in IR and HR prostate cancer patients through local BED escalation. The improvement in BC was observed in patients receiving higher BED, as well as a significant association between BED and risk of biochemical failure.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要